In a U.S. Food and Drug Administration’s FDA Voice blog post, FDA Budget Matters: Investing in Advanced Domestic Manufacturing, FDA Commissioner Dr. Scott Gottlieb opened noting: Advanced manufacturing, which includes various technologies, such as continuous manufacturing and 3D printing, holds great promise for improving the American market for drugs and biologicals. Emerson’s Ron Rossbach shared […]
Author: Emily Anderson Flexible facilities are a growing trend in the biopharmaceutical manufacturing industry. Manufacturers increasingly look to produce multiple products and maximize production time. To meet these requirements, an automation strategy must maximize the flexibility of the process equipment. The preparation, storage, and distribution of media often requires real-time flowpath selection and bumpless transfer […]
While integration technologies have helped bridge “islands of automation” over the years, some process manufacturers still have parts of their automated processes disconnected from the rest. Emerson’s Gary Mitchell, a senior industry consultant on the Life Sciences industry team, shares some recent experiences on bridging these islands. I’m spending a lot of my time recently […]
Powered by WordPress